Abstract

Management of salivary gland hypofunction caused by irradiation (IR) therapy for head and neck cancer remains lack of effective treatments. Salivary glands, especially the parotid gland, actively uptake dietary nitrate and secrete it into saliva. Here, we investigated the effect of dietary nitrate on the prevention and treatment of IR-induced parotid gland hypofunction in miniature pigs, and elucidated the underlying mechanism in human parotid gland cells (hPGCs). We found that nitrate administration prevented IR-induced parotid gland damage in a dose-dependent manner, by maintaining the function of irradiated parotid gland tissue. Nitrate could increase sialin expression, a nitrate transporter expressed in the parotid gland, making the nitrate-sialin feedback loop that facilitates nitrate influx into cells for maintaining cell proliferation and inhibiting apoptosis. Furthermore, nitrate enhanced cell proliferation via the epidermal growth factor receptor (EGFR)-protein kinase B (AKT)-mitogen-activated protein kinase (MAPK) signaling pathway in irradiated parotid gland tissue. Collectively, nitrate effectively prevented IR-induced xerostomia via the EGFR–AKT-MAPK signaling pathway. Dietary nitrate supplementation may provide a novel, safe, and effective way to resolve IR-induce xerostomia.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for: Figure 1G, Figure 2E, Figure 3A-D, and Figure 6 A,C,D and E, available on Dryad Digital Repository (doi:10.5061/dryad.fn2z34ttq).

The following data sets were generated

Article and author information

Author details

  1. Xiaoyu Feng

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Zhifang Wu

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Junji Xu

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  4. Yipu Xu

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  5. Bin Zhao

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  6. Baoxing Pang

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  7. Xingmin Qu

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  8. Liang Hu

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  9. Lei Hu

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  10. Zhipeng Fan

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  11. Luyuan Jin

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  12. Dengsheng Xia

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  13. Shimin Chang

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  14. Jingsong Wang

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  15. Chunmei Zhang

    Capital Medical University School of Stomatology, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  16. Songlin Wang

    Capital Medical University School of Stomatology, Beijing, China
    For correspondence
    slwang@ccmu.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7066-2654

Funding

National Natural Science Foundation of China (82030031)

  • Songlin Wang

National Natural Science Foundation of China (91649124)

  • Songlin Wang

National Natural Science Foundation of China (81600883)

  • Songlin Wang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal studies were conducted according to the NIH's Guide for the Care and Use of Laboratory Animals, and approved by the Animal Care and Use Committee of Capital Medical University

Human subjects: Human parotid gland biopsy sample was obtained under a protocol approved by the ethics committee of Beijing Stomatological Hospital, Capital Medical University

Copyright

© 2021, Feng et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,223
    views
  • 294
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Xiaoyu Feng
  2. Zhifang Wu
  3. Junji Xu
  4. Yipu Xu
  5. Bin Zhao
  6. Baoxing Pang
  7. Xingmin Qu
  8. Liang Hu
  9. Lei Hu
  10. Zhipeng Fan
  11. Luyuan Jin
  12. Dengsheng Xia
  13. Shimin Chang
  14. Jingsong Wang
  15. Chunmei Zhang
  16. Songlin Wang
(2021)
Dietary nitrate supplementation prevents radiotherapy-induced xerostomia
eLife 10:e70710.
https://doi.org/10.7554/eLife.70710

Share this article

https://doi.org/10.7554/eLife.70710

Further reading

    1. Cell Biology
    2. Stem Cells and Regenerative Medicine
    Liyi Wang, Shiqi Liu ... Tizhong Shan
    Research Article

    Conjugated linoleic acids (CLAs) can serve as a nutritional intervention to regulate quality, function, and fat infiltration in skeletal muscles, but the specific cytological mechanisms remain unknown. Here, we applied single-nucleus RNA-sequencing (snRNA-seq) to characterize the cytological mechanism of CLAs regulates fat infiltration in skeletal muscles based on pig models. We investigated the regulatory effects of CLAs on cell populations and molecular characteristics in pig muscles and found CLAs could promote the transformation of fast glycolytic myofibers into slow oxidative myofibers. We also observed three subpopulations including SCD+/DGAT2+, FABP5+/SIAH1+, and PDE4D+/PDE7B+ subclusters in adipocytes and CLAs could increase the percentage of SCD+/DGAT2+ adipocytes. RNA velocity analysis showed FABP5+/SIAH1+ and PDE4D+/PDE7B+ adipocytes could differentiate into SCD+/DGAT2+ adipocytes. We further verified the differentiated trajectory of mature adipocytes and identified PDE4D+/PDE7B+ adipocytes could differentiate into SCD+/DGAT2+ and FABP5+/SIAH1+ adipocytes by using high intramuscular fat (IMF) content Laiwu pig models. The cell-cell communication analysis identified the interaction network between adipocytes and other subclusters such as fibro/adipogenic progenitors (FAPs). Pseudotemporal trajectory analysis and RNA velocity analysis also showed FAPs could differentiate into PDE4D+/PDE7B+ preadipocytes and we discovered the differentiated trajectory of preadipocytes into mature adipocytes. Besides, we found CLAs could promote FAPs differentiate into SCD+/DGAT2+ adipocytes via inhibiting c-Jun N-terminal kinase (JNK) signaling pathway in vitro. This study provides a foundation for regulating fat infiltration in skeletal muscles by using nutritional strategies and provides potential opportunities to serve pig as an animal model to study human fat infiltrated diseases.

    1. Cancer Biology
    2. Cell Biology
    Zuzana Outla, Gizem Oyman-Eyrilmez ... Martin Gregor
    Research Article

    The most common primary malignancy of the liver, hepatocellular carcinoma (HCC), is a heterogeneous tumor entity with high metastatic potential and complex pathophysiology. Increasing evidence suggests that tissue mechanics plays a critical role in tumor onset and progression. Here, we show that plectin, a major cytoskeletal crosslinker protein, plays a crucial role in mechanical homeostasis and mechanosensitive oncogenic signaling that drives hepatocarcinogenesis. Our expression analyses revealed elevated plectin levels in liver tumors, which correlated with poor prognosis for HCC patients. Using autochthonous and orthotopic mouse models we demonstrated that genetic and pharmacological inactivation of plectin potently suppressed the initiation and growth of HCC. Moreover, plectin targeting potently inhibited the invasion potential of human HCC cells and reduced their metastatic outgrowth in the lung. Proteomic and phosphoproteomic profiling linked plectin-dependent disruption of cytoskeletal networks to attenuation of oncogenic FAK, MAPK/Erk, and PI3K/Akt signatures. Importantly, by combining cell line-based and murine HCC models, we show that plectin inhibitor plecstatin-1 (PST) is well-tolerated and potently inhibits HCC progression. In conclusion, our study demonstrates that plectin-controlled cytoarchitecture is a key determinant of HCC development and suggests that pharmacologically induced disruption of mechanical homeostasis may represent a new therapeutic strategy for HCC treatment.